Literature DB >> 35227161

Sex differences in the pharmacokinetics and tissue residues of Macleaya cordata extracts in rats.

Li-Xia Shen1, Gao-Feng Liu2, Ji-Shuang Song1, Yu-Hang Cao1, Xiong Peng1, Rong-Rong Wu1, Yan Cao1, Xiao-Jun Chen1, Zhaoying Liu1, Zhi-Liang Sun1, Yong Wu1,2.   

Abstract

Macleaya cordata extracts (MCE) are listed as feed additives in animal production by the European Food Authority. The core components of MCE are mainly sanguinarine (SA) and chelerythrine (CHE). This study aims to investigate sex differences in the pharmacokinetics and tissue residues of MCE in rats.Male and female rates were intragastrically administered MCE (1.25 mg·kg-1 body weight and 12.5 mg·kg-1 body weight dose for 28 days). SA and CHE concentrations were determined using high-performance liquid chromatography/tandem mass spectrometry.The peak plasma concentration (Cmax) and area under the curve (AUC) of both CHE and SA were higher in female than in male rats (12.5 mg·kg-1 body weight group), whereas their half-life (T1/2) and apparent volume of distribution (Vd) was lower (p < 0.05). Tissue rfesidue analysis indicated that SA and CHE were more distributed in male than in female rats and were highly distributed in the caecum and liver. SA and CHE were completely eliminated from the liver, kidney, lung, heart, spleen, leg muscle, and caecum after 120 h, indicating they did not accumulate in rats for a long time.Overall, we found that the pharmacokinetics and tissue residues of SA and CHE of male and female rats showed sex differences.

Entities:  

Keywords:  Macleaya cordata extracts; chelythrine; pharmacokinetics; sanguinarine; sex differences; tissue residues

Mesh:

Substances:

Year:  2022        PMID: 35227161     DOI: 10.1080/00498254.2022.2048323

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  1 in total

Review 1.  Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine.

Authors:  Nianzhi Chen; Yulin Qi; Xiao Ma; Xiaolin Xiao; Qingsong Liu; Ting Xia; Juyi Xiang; Jinhao Zeng; Jianyuan Tang
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.